Experimental COVID-19 drug SIR1-365 put to the test in early trial
NCT ID NCT04622332
First seen Nov 12, 2025 · Last updated May 23, 2026 · Updated 31 times
Summary
This early-stage study tested a new drug called SIR1-365 in 45 hospitalized adults with severe COVID-19. The main goal was to see if the drug is safe and tolerable. Researchers also looked at whether it could reduce inflammation and help patients recover. The study was completed, but results are not yet available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONA VIRUS INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Aga Khan University Hospital
Karachi, Sindh, 74800, Pakistan
-
Baptist Medical Center
Jackson, Mississippi, 39202, United States
-
Dow University Hospital, Ojha Karachi
Karachi, Sindh, 74200, Pakistan
-
Hospital Civil Fray Antonio Alcalde
Guadalajara, Jalisco, 14050, Mexico
-
Hospital Universitario "Dr. José Eleuterio González"
Monterrey, Nuevo León, 64460, Mexico
-
Media Sur - Medica Sur Tlalpan
Tlalpan, Mexico City, 14050, Mexico
-
OSF St. Francis Medical Center
Peoria, Illinois, 61637, United States
-
Sindh Infectious Disease Hospital
Karachi, Sindh, 74200, Pakistan
-
Triple O Research Institute
West Palm Beach, Florida, 33407, United States
Conditions
Explore the condition pages connected to this study.